Tech Company Financing Transactions
Arcxis Biotechnologies Funding Round
Claremont Creek Ventures and Kaiser Permanente Ventures invested in a Series B funding round for Arcxis Biotechnologies. The round was announced on 1/30/2009.
Transaction Overview
Company Name
Announced On
1/30/2009
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
Claremont Creek Ventures (Lead Investor) (John Steuart)
Proceeds Purpose
These funds will enable Arcxis to accelerate development, testing, and commercialization of their innovative nucleic acid sample preparation platform and their next generation sample to answer clinical molecular diagnostic platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6920 Koll Center Pkwy. 215
Pleasanton, CA 94566
USA
Pleasanton, CA 94566
USA
Phone
Website
Email Address
Overview
Arcxis Biotechnologies is focused on developing elegant, integrated and compact solutions to molecular diagnostic challenges.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christine Meda
Chief Technical Officer
Jay West
Browse more venture capital transactions:
Prev: 1/30/2009: Diagnosoft venture capital transaction
Next: 1/30/2009: PayScale venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs